These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22134880)

  • 1. Validity of the Oxford classification of IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
    Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study.
    Kamano C; Shimizu A; Joh K; Hashiguchi A; Hisano S; Katafuchi R; Kawamura T;
    Clin Exp Nephrol; 2021 May; 25(5):509-521. PubMed ID: 33595730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
    Mizerska-Wasiak M; Małdyk J; Rybi-Szumińska A; Wasilewska A; Miklaszewska M; Pietrzyk J; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Turczyn A; Roszkowska-Blaim M
    Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
    Zeng CH; Le W; Ni Z; Zhang M; Miao L; Luo P; Wang R; Lv Z; Chen J; Tian J; Chen N; Pan X; Fu P; Hu Z; Wang L; Fan Q; Zheng H; Zhang D; Wang Y; Huo Y; Lin H; Chen S; Sun S; Wang Y; Liu Z; Liu D; Ma L; Pan T; Zhang A; Jiang X; Xing C; Sun B; Zhou Q; Tang W; Liu F; Liu Y; Liang S; Xu F; Huang Q; Shen H; Wang J; Shyr Y; Phillips S; Troyanov S; Fogo A; Liu ZH
    Am J Kidney Dis; 2012 Nov; 60(5):812-20. PubMed ID: 22819700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
    Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
    BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy.
    Shima Y; Nakanishi K; Hama T; Sato M; Mukaiyama H; Togawa H; Tanaka R; Kaito H; Nozu K; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2015 Feb; 30(2):293-9. PubMed ID: 24912604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis.
    Huang X; Ma L; Ren P; Wang H; Chen L; Han H; Chen J; Han F
    Diagn Pathol; 2019 May; 14(1):40. PubMed ID: 31077245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.